Haemostasis Research Group, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland.
National Coagulation Centre, St James's Hospital, Dublin, Ireland.
Br J Haematol. 2018 Oct;183(2):185-195. doi: 10.1111/bjh.15565.
The mechanisms involved in regulating von Willebrand factor (VWF) clearance remain poorly understood. However recent studies have shown that macrophages play a critical role in regulating the half-life of VWF, and have identified specific lectin (including asialoglycoprotein, macrophage galactose-type lectin, Sigec-5 and C-type lectin domain family 4 member M) and scavenger receptors (including low-density lipoprotein receptor-related protein-1, scavenger receptor A1 and stabilin-2) that are involved in VWF clearance. Further studies will be required to determine the relative importance of these individual receptors with respect to physiological and pathological VWF clearance. Nevertheless, recent clinical data have highlighted the importance of enhanced VWF clearance in the pathogenesis of type 1 von Willebrand disease (VWD). Moreover, increased clearance also contributes to reduced VWF levels in many patients with type 2 and type 3 VWD. Improved understanding regarding VWF clearance is not only of direct biological relevance, but may also have important implications for the development of novel therapeutic agents with extended plasma half-lives for the treatment of both VWD and haemophilia A.
调控血管性血友病因子(VWF)清除的机制仍知之甚少。然而,最近的研究表明,巨噬细胞在调节 VWF 半衰期方面发挥着关键作用,并确定了参与 VWF 清除的特定凝集素(包括唾液酸糖蛋白、巨噬细胞半乳糖型凝集素、Sigec-5 和 C 型凝集素域家族 4 成员 M)和清道夫受体(包括低密度脂蛋白受体相关蛋白-1、清道夫受体 A1 和稳定素-2)。需要进一步研究来确定这些单个受体在生理和病理 VWF 清除方面的相对重要性。然而,最近的临床数据强调了增强的 VWF 清除在 1 型血管性血友病(VWD)发病机制中的重要性。此外,清除增加也导致许多 2 型和 3 型 VWD 患者的 VWF 水平降低。对 VWF 清除的更好理解不仅具有直接的生物学相关性,而且可能对开发具有延长血浆半衰期的新型治疗药物以治疗 VWD 和血友病 A 具有重要意义。